glp 1 agonist schizophrenia Antipsychotic-Induced Weight Gain: Are GLP-1 Agonists Effective? GLP-1 Receptor Agonists and Research
Description
Some patients may qualify for one product under one pathway and another product under a different one
A 2023 JAMA study associates GLP-1 agonists with an increased risk of several conditions, including gastroparesis
Cardiovascular and mortality benefits in psoriatic arthritis In a large retrospective analysis of more than 90,000 psoriatic arthritis (PsA) patients, Tsibadze et al (Abstract 0849) reported that GLP-1RA use was linked to lower risk of major adverse cardiovascular events (MACE) and reduced all-cause mortality compared with PsA patients not taking GLP-1RA
Oral semaglutide has proven to be noninferior to placebo in high-risk patients in a pre-approval study (30), and a larger trial to evaluate the long-term cardiovascular benefit of oral semaglutide is ongoing (NCT03914326)
Der Grundumsatz sinkt - ein ganz natrlicher Schutzmechanismus, der uns seit Urzeiten begleitet
